Raymond James & Associates’s Vanda Pharmaceuticals VNDA Stock Holding History

Raymond James & Associates’s Portfolio VNDA Stock Details VNDA Fund Activity

Upgrade to unlock

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell
2024 Q1	$41.1K	Hold
2023 Q4	$42.2K	Buy
2016 Q2	–	Sell
2016 Q1	$159K	Buy